¬
P. Cla pes et al.
FULL PAPER
minor 18: d 67.6 (C4), 66.2 (C3), 60.3 (C2), 59.9 (C7), 42.2 (C6), 24.5 ppm
3H; H6); 13C NMR (125 MHz, D2O, 25 8C): d 80.3 (C4), 75.8 (C3), 62.4
(C5).
(C2), 59.6 (C7), 57.3 (C5), 15.4 ppm (C6).
(2S,3S,4S,5R)-2-Hydroxymethyl-5-methylpyrrolidine-3,4-diol (27) and
(2R,3S,4R,5R)-2-hydroxymethyl-5-methylpyrrolidine-3,4-diol (28): The ti-
tle compounds were prepared according to the general procedure described
above. 1H NMR (500 MHz, D2O, 25 8C) major 27: d 4.1 (dd, 3J(H,H)
1.4 Hz, 3J(H,H) 3.2 Hz, 1H; H4), 4.0 (dd, 3J(H,H) 1.8 Hz, 3J(H,H)
3.2 Hz, 1H; H3), 3.8 (dd, 3J(H,H) 4.9 Hz, 3J(H,H) 11.9 Hz, 1H; H7),
(2R,3R,4R)-2-(Hydroxymethyl)pyrrolidine-3,4-diol (19): The title com-
pound was prepared according to the general procedure described above.
3
3
1H NMR (500 MHz, D2O, 25 8C): d 4.2 (m, J(H,H) 2.8 Hz, J(H,H)
3
3
3.9 Hz, J(H,H) 5.0 Hz, 1H; H4), 3.9 (t, J(H,H) 3.9 Hz, 1H; H3), 3.8
(dd, 3J(H,H) 4.9 Hz, 3J(H,H) 11.9 Hz, 1H; H6), 3.7 (dd, 3J(H,H)
7.0 Hz, 3J(H,H) 11.9 Hz, 1H; H6), 3.4 (dd, 3J(H,H) 5.0 Hz, 3J(H,H)
12.3 Hz, 1H; H5), 3.3 (m, 3J(H,H) 3.9 Hz, 3J(H,H) 4.9 Hz, 3J(H,H)
7.3 Hz, 1H; H2), 3.1 ppm (dd, 3J(H,H) 2.8 Hz, 3J(H,H) 12.3 Hz, 1H;
H5); 13C NMR (125 MHz, D2O): d 76.5 (C3), 75.1 (C4), 66.6 (C2), 59.7
(C6), 50.2 ppm (C5).
3
3
3
3.75 (dq, J(H,H) 3.5 Hz, J(H,H) 6.5 Hz, 1H; H5), 3.7 (dd, J(H,H)
8.8 Hz, 3J(H,H) 12.3 Hz, 1H; H7), 3.5 (dt, 3J(H,H) 3.3 Hz, 3J(H,H)
5.1 Hz, 3J(H,H) 8.2 Hz, 1H; H2), 1.3 ppm (d, 3J(H,H) 6.7 Hz, 3H; H6);
minor 28: d 4.3 (t, 3J(H,H) 3.7 Hz, 1H; H3), 3.95 (dd, 3J(H,H) 3.7 Hz,
3J(H,H) 9 Hz, 1H; H4), 3.9 (dd, 3J(H,H) 4.7 Hz, 3J(H,H) 11.8 Hz,
3
3
(2R,3R,4R,5S)-2-Hydroxymethyl-5-methylpyrrolidine-3,4-diol (20): The
title compound was prepared according to the general procedure described
above. 1H NMR (500 MHz, D2O, 25 8C): d 4.1 (dd, 3J(H,H) 1.4 Hz,
3J(H,H) 3.2 Hz, 1H; H4), 4.0 (dd, 3J(H,H) 1.8, 3J(H,H) 3.2, 1H; H3),
3.8 (dd, 3J(H,H) 4.9 Hz, 3J(H,H) 11.9 Hz, 1H; H7), 3.75 (dq, 3J(H,H)
3.5 Hz, 3J(H,H) 6.5 Hz, 1H; H5), 3.7 (dd, 3J(H,H) 8.8 Hz, 3J(H,H)
12.3 Hz, 1H; H7), 3.5 (dt, 3J(H,H) 3.3 Hz, 3J(H,H) 5.1 Hz, 3J(H,H)
8.2 Hz, 1H; H2), 1.3 ppm (d, 3J(H,H) 6.7 Hz, 3H; H6); 13C NMR
(125 MHz, D2O, 25 8C): d 76.3 (C4), 76.3 (C3), 67.5 (C2), 59.6 (C7), 58.3
(C5), 10.7 ppm (C6).
1H; H7), 3.8 (dd, J(H,H) 8.4 Hz, J(H,H) 11.8 Hz, 1H; H7), 3.75 (m,
3J(H,H) 3.7 Hz, 3J(H,H) 4.7 Hz, 3J(H,H) 8.4 Hz, 1H; H2), 3.5 (m,
1H; H5), 1.3 ppm (d, 3J(H,H) 6.7 Hz, 3H; H6); 13C NMR (125 MHz,
D2O, 25 8C) major 27: d 76.3 (C4), 76.3 (C3), 67.5 (C2), 59.6 (C7), 58.3
(C5), 10.7 ppm (C6); minor 28: d 76.7 (C4), 70.4 (C3), 61.5 (C2), 58.4
(C7), 56.7 (C5), 15.0 ppm (C6).
Acknowledgement
Financial support from the Spanish M.C.Y.T. Plan Nacional (grants QUI99-
0997CO2-01, BIO99-1219-C02-02 and PPQ2002-04625-C02-01) and from
Generalitat de Catalunya (grant 2000SGR-00357) is acknowledged.
(2R,3R,4R,5R)-2-Hydroxymethyl-5-methylpyrrolidine-3,4-diol (21): The
title compound was prepared according to the general procedure described
above. 1H NMR (500 MHz, D2O, 25 8C): d 3.9 (t, 3J(H,H) 7 Hz, 1H;
H3), 3.8 (dd, 3J(H,H) 4.2 Hz, 3J(H,H) 12.0 Hz, 1H; H7), 3.75 (t,
3J(H,H) 7.5 Hz, 1H; H4), 3.7 (dd, 3J(H,H) 6.4 Hz, 3J(H,H) 12.0 Hz,
1H; H7), 3.35 (dt, 3J(H,H) 4.2 Hz, 3J(H,H) 6.4 Hz, 3J(H,H) 7.0 Hz,
1H; H2), 3.3 (dq, 3J(H,H) 7.0 Hz, 1H; H5), 1.3 ppm (d, 3J(H,H) 7.0 Hz,
3H; H6); 13C NMR (75 MHz, D2O, 25 8C): d 80.3 (C4), 75.8 (C3), 62.4
(C2), 59.6 (C7), 57.3 (C5), 15.4 ppm (C6).
[1] T. D. Machajewski, C. H. Wong, Angew. Chem. 2000, 112, 1406 1430;
Angew. Chem. Int. Ed. 2000, 39, 1353 1374.
[2] W. D. Fessner, V. Helaine, Curr. Opin. Biotechnol. 2001, 12, 574 586.
[3] C.-H. Wong, R. L. Halcomb, Y. Ichikawa, T. Kajimoto, Angew. Chem.
1995, 107, 453 474; Angew. Chem. Int. Ed. Engl. 1995, 34, 412 432.
[4] G. C. Look, C. H. Fotsch, C. H. Wong, Acc. Chem. Res. 1993, 26, 182
190.
[5] C. H. Wong, Trends Biotechnol. 1992, 10, 337 341.
[6] S. Takayama, R. Martin, J. Wu, K. Laslo, G. Siuzdak, C.-H. Wong, J.
Am. Chem. Soc. 1997, 119, 8146 8151.
[7] M. H. Fechter, A. E. Stutz, A. Tauss, Curr. Org. Chem. 1999, 3, 269
285.
[8] C.-H. Wong, L. Provencher, J. A. Porco, Jr., S.-H. Jung, Y.-F. Wang, L.
Chen, R. Wang, D. H. Steensma, J. Org. Chem. 1995, 60, 1492 1501.
[9] A. E. Stutz, Iminosugars as Glycosidase Inhibitors. Nojirimicin and
Beyond, Wiley-VCH, Weinheim, 1999.
(2S,3S,4S)-2-(Hydroxymethyl)piperidine-3,4-diol (22) and (2R,3S,4R)-2-
(hydroxymethyl)piperidine-3,4-diol (23): The title compounds were pre-
pared according to the general procedure described above. 1H NMR
(500 MHz, D2O, 25 8C) major 22: d 3.84 (dd, 3J(H,H) 3.2, 3J(H,H)
12.6 Hz, 1H; H7), 3.77 (dd, 3J(H,H) 5.7 Hz, 3J(H,H) 12.7 Hz, 1H; H7),
3.6 (dt, 3J(H,H) 4.9 Hz, 3J(H,H) 9.5 Hz, 3J(H,H) 11.6 Hz, 1H; H4),
3.4 (t, 1H; H3), 3.3 (br, 1H; H6), 3.0 (m, 1H; H2), 2.95 (dt, 3J(H,H)
3.2 Hz, 3J(H,H) 13.1 Hz, 1H; H6), 2.1 (br, 1H; H5), 1.6 ppm (dq,
3J(H,H) 4.3 Hz, 1H; H5); minor 23: d 4.0 (1H; H3), 3.80 (1H; H4), 3.2
(1H; H2), 1.95 (1H; H5), 1.85 (1H; H5), 3.76 (dd, 1H; H7), 3.72 (dd, 1H;
H7), 2.95 (1H; H6), 3.0 ppm (1H; H6); 13C NMR (125 MHz, D2O, 25 8C)
major 22: d 70.5 (C4), 69.7 (C3), 60.0 (C2), 57.9 (C7), 41.7 (C6), 28.8 ppm
(C5); minor 23: d 67.6 (C4), 66.2 (C3), 60.3 (C2), 59.9 (C7), 42.2 (C6),
24.5 ppm (C5).
[10] V. H. Lillelund, H. H. Jensen, X. Liang, M. Bols, Chem. Rev. 2002, 102,
515 553.
[11] R. R. Hung, J. A. Straub, G. M. Whitesides, J. Org. Chem. 1991, 56,
3849 3855.
[12] J. Jurczak, A. Golebiowski, Chem. Rev. 1989, 89, 149 164.
[13] J. Jurczak, D. Gryko, E. Kobrzycka, H. Gruza, P. Prokopowicz,
Tetrahedron 1998, 54, 6051 6064.
[14] M. Schuster, Bioorg. Med. Chem. Lett. 1999, 9, 615 618.
[15] C. H. Von der Osten, A. J. Sinskey, C. F. Barbas, III, R. L. Pederson,
Y. F. Wang, C. H. Wong, J. Am. Chem. Soc. 1989, 111, 3924 3927.
[16] A. Romero, C. H. Wong, J. Org. Chem. 2000, 65, 8264 8268.
[17] R. L. Pederson, C. H. Wong, Heterocycles 1989, 28, 477 480.
[18] L. Azema, F. Bringaud, C. Blonski, J. Perie, Bioorg. Med. Chem. 2000,
8, 717 722.
(2S,3S,4S)-2-(Hydroxymethyl)pyrrolidine-3,4-diol (24) and (2R,3S,4R)-2-
(hydroxymethyl)pyrrolidine-3,4-diol (25): The title compounds were pre-
pared according to the general procedure described above. 1H NMR
(500 MHz, D2O, 25 8C) major 24: d 4.2 (m, 3J(H,H) 2.8, 3J(H,H)
3
3
3.9 Hz, J(H,H) 5.0 Hz, 1H; H4), 3.9 (t, J(H,H) 3.9 Hz, 1H; H3), 3.8
(dd, 3J(H,H) 4.9 Hz, 3J(H,H) 11.9 Hz, 1H; H6), 3.7 (dd, 3J(H,H)
7.0 Hz, 3J(H,H) 11.9 Hz, 1H; H6), 3.4 (dd, 3J(H,H) 5.0 Hz, 3J(H,H)
12.3 Hz, 1H; H5), 3.3 (m, 3J(H,H) 3.9 Hz, 3J(H,H) 4.9 Hz, 3J(H,H)
7.3 Hz, 1H; H2), 3.1 ppm (dd, 3J(H,H) 2.8 Hz, 3J(H,H) 12.3 Hz, 1H;
3
3
3
H5); minor 25: d 4.4 (dt, J(H,H) 3.8 Hz, J(H,H) 4.3 Hz, J(H,H)
7.3 Hz, 1H; H4), 4.2 (t, 1H; H3), 3.9 (dd, 3J(H,H) 4.9 Hz, 3J(H,H)
3
3
12.0 Hz, 1H; H6), 3.8 (dd, J(H,H) 6.6 Hz, J(H,H) 12.3 Hz, 1H; H6),
3.6 (m, 1H; H2), 3.3 (dd, 3J(H,H) 4.3 Hz, 3J(H,H) 12.0 Hz, 1H; H5),
3.4 ppm (dd, 3J(H,H) 7.3 Hz, 3J(H,H) 12.3 Hz, 1H; H5); 13C NMR
(125 MHz, D2O, 25 8C) major 24: d 76.5 (C3), 75.1 (C4), 66.6 (C2), 59.7
(C6), 50.2 ppm (C5); minor 25: d 70.5 (C3), 70.7 (C4), 63.2 (C2), 58.4
(C6), 47.9 ppm (C5).
[19] S. B. Sobolov, A. Bartoszko-Malik, T. R. Oeschger, M. M. Montelba-
no, Tetrahedron Lett. 1994, 35, 7751 7754.
¬
[20] P. Clapes, L. Espelt, M. A. Navarro, C. Solans, J. Chem. Soc. Perkin
Trans. 2 2001, 1394 1399.
¬
[21] L. Espelt, P. Clapes, J. Esquena, A. Manich, C. Solans, Langmuir 2003,
19, 1337 1346.
(2S,3S,4S,5S)-2-Hydroxymethyl-5-methylpyrrolidine-3,4-diol (26): The ti-
[22] C. Solans, R. Pons, H. Kunieda, in Modern Aspects of Emulsion
Science (Ed.: B. P. Binks), The Royal Society of Chemistry, Cam-
bridge, 1998, pp. 367 394.
[23] Swern oxidation of alcohol 3 furnished 7 with lower optical purity
than that obtained with IBX.
tle compound was prepared according to the general procedure described
1
3
above. H NMR (500 MHz, D2O, 25 8C): d 3.9 (t, J(H,H) 7.0 Hz, 1H;
H3), 3.8 (dd, 3J(H,H) 4.2 Hz, 3J(H,H) 12.0 Hz, 1H; H7), 3.75 (t,
3J(H,H) 7.5 Hz, 1H; H4), 3.7 (dd, 3J(H,H) 6.4 Hz, 3J(H,H) 12.0 Hz,
1H; H7), 3.35 (dt, 3J(H,H) 4.2 Hz, 3J(H,H) 6.4 Hz, 3J(H,H) 7.0 Hz,
1H; H2), 3.3 (dq, 3J(H,H) 7.0 Hz, 1H; H5), 1.3 ppm (d, 3J(H,H) 7.0 Hz,
[24] M. Frigerio, M. Santagostino, S. Sputore, J. Org. Chem. 1999, 64,
4537 4538.
4898
¹ 2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2003, 9, 4887 4899